Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

JENAVALVE ALIGN-AS TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)

NCT02732691 is registered in ClinicalTrials.gov with JenaValve Technology, Inc. as lead sponsor.

NCT NCT02732691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02732691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
JENAVALVE ALIGN-AS TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)
Lead sponsor
JenaValve Technology, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
October 21, 2016
Completion date
April 30, 2024
Enrollment
68 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis, cardiovascular diseases, heart diseases, heart valve diseases, ventricular outflow obstruction